ClinicalTrials.gg
CompletedNCT07944131Music TherapyUpdated Nov 18, 2026

Music Therapy for Anxiety Reduction During Cervical Ripening

An interventional study of Music intervention in Anxiety, Labor Anxiety and Labor Induction, sponsored by Meir Medical Center. Completed at 1 site in Israel. Open to female participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-18.

Primary conditionAnxiety Disorders(the registry's first term)UnverifiedIs this wrong?The registry often attaches Anxiety Disorders to studies about something else, and this study's title and listed conditions do not name it. No better condition is named, so the registry's term is kept.

Sponsored by Meir Medical Center · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 5 years after the study started (first participant enrolled Oct 2021, registered Nov 2026).
Updated Nov 18, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
102
Allocation
Non-randomized
Ages
18 Years to 50 Years
Sex
Female
01

Study summary

Induction of labor is a common procedure used to start labor when delivery is recommended. The process may involve cervical ripening, which helps prepare the cervix for labor. This period can be associated with anxiety and discomfort for pregnant patients. Music therapy may help reduce anxiety and improve the experience of care during this process.

The purpose of this study was to evaluate whether a 45-minute individualized music therapy session could reduce anxiety among patients undergoing cervical ripening as part of labor induction. The study was conducted at Meir Medical Center, a tertiary hospital in Kfar Saba, Israel.

A total of 102 patients with singleton term pregnancies who were undergoing cervical ripening with a vaginal Cervidil pessary participated in the study. Patients were assigned to either a music therapy group or a control group according to the availability of a music therapist. The music therapy group received an individualized 45-minute session delivered by a certified music therapist, while the control group received standard obstetric care without a music therapy session.

Anxiety, pain, and salivary cortisol levels (a measure of the body's stress response) were assessed before and after the intervention. The researchers compared the changes in these measurements between the two groups to evaluate whether music therapy was associated with reduced anxiety and stress during cervical ripening.

02

Conditions studied

  • Anxiety
  • Labor Anxiety
  • Labor Induction
  • Stress (Psychology)

Browse trials for

Keywords

  • Music, Music therapy, induction of labor, anxiety, cortisol, STAI, Cervical ripening
03

In context

Anxiety Disorders Unverified

7,238 studies on the registry are indexed under Anxiety Disorders; 1,687 are open to participants now.

This study's enrollment of 102 is above the median of 80 across 6,092 interventional studies indexed under Anxiety Disorders.

Browse Anxiety Disorders studies →

Lead sponsor

Meir Medical Center is the lead sponsor of 402 studies on the registry; 26 are open to participants now.

Compared within Anxiety Disorders, the registry's first condition term, which may not be this study's main condition. Counted across the registry records on this site, refreshed daily. How we classify →

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age ≥18 years.
  • Singleton term pregnancy.
  • Planned cervical ripening with Cervidil (dinoprostone vaginal pessary) as part of routine obstetric care.

Exclusion criteria

Exclusion Criteria

  • Current use of anxiolytic or antidepressant medication.
  • Diagnosed mental health disorder.
  • Cervical ripening using methods other than Cervidil.
  • Multiple gestation.
  • Induction of labor with a favorable cervix (Bishop score >6, as assessed by an obstetrician).
  • Known fetal anomalies or chromosomal abnormalities.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
102 participants (actual)

Study arms

  • Experimental
    Music therapy

    Participants received an individualized 45-minute music therapy session delivered by a certified music therapist during the cervical ripening period. The session was provided in addition to standard obstetric care.

    Other: Music intervention

  • No intervention
    Control Group

    articipants received standard obstetric care during the cervical ripening period, without a music therapy session.

Interventions

  • OtherMusic intervention

    Participants received an individualized 45-minute music therapy session delivered by a certified music therapist during the cervical ripening period. The session was provided in addition to standard obstetric care.

06

What researchers measure

Primary outcomes

  1. State Anxiety (STAI-S)

    State anxiety was assessed using the State subscale of the State-Trait Anxiety Inventory (STAI-S), a validated 20-item questionnaire. Total scores range from 20 to 80, with higher scores indicating greater anxiety. The outcome was the change in STAI-S score from baseline to the post-intervention assessment, calculated as post-intervention minus baseline score. Negative values indicate reduced anxiety.

    Time frame: 45 minutes

  2. Salivary Cortisol

    Salivary cortisol concentration was measured in micrograms per deciliter (µg/dL) as an objective physiological marker of stress. Saliva samples were collected before and after the intervention or corresponding control period. The outcome was the change in cortisol concentration, calculated as the post-intervention value minus the baseline value. Negative values indicate a reduction in cortisol levels.

    Time frame: 45 minutes

  3. Subjective Anxiety Score

    Participants rated their perceived anxiety on a numerical scale ranging from 0 (no anxiety) to 10 (maximum anxiety). Anxiety was assessed before and after the intervention or corresponding control period. The outcome was the change in anxiety score, calculated as post-intervention minus baseline score. Negative values indicate reduced anxiety.

    Time frame: 45 minutes

  4. Pain Intensity (VAS)

    Pain intensity was assessed using a visual analog scale (VAS) ranging from 0 (no pain) to 10 (worst imaginable pain). Pain was assessed before and after the intervention or corresponding control period. The outcome was the change in VAS score, calculated as post-intervention minus baseline score. Negative values indicate reduced pain intensity.

    Time frame: 45 minutes

07

Study locations

1 site
  • Meir Medical Center
    Kfar Saba, Central District, Israel
08

References and documents

Individual participant data

Plan to share: No — Writing Individual participant data will not be shared because data sharing was not permitted under the institutional Helsinki Committee approval and the study's applicable ethical requirements.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Oct 2021 to primary completion in Feb 2024, 28 months.

Of 3,866 non-industry interventional studies with no phase under Anxiety Disorders, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 28. This study's 28 months is above that.

Counting every sponsor, half of 3,969 studies reached it within 12 months; a quarter within 5 and three quarters within 28.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 12, 2026
First posted
Nov 18, 2026
StartActual
Oct 18, 2021
Primary completionActual
Feb 18, 2024
CompletionActual
Feb 28, 2024
Last update
Nov 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 18, 2026
Show all 1 update
  1. Nov 18, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07944131
Responsible party
Gal Cohen (Gal Cohen, Senior Physician in OBGYN and a resident in Medical Genetics, Meir Medical Center) — Principal investigator
First posted
Nov 18, 2026
Start date
Oct 18, 2021
Primary completion
Feb 18, 2024
Completion
Feb 28, 2024
Last update
Nov 18, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion